A AB BS S T TR RA AC CT T O Ob b j je ec c t ti i v ve e: : Beh çet's di se a se (BD) is a chro nic syste mic inf lam ma tory di se a se and its etio pat ho ge ne sis still re ma ins unk nown. Cyto ki nes play a ro le in im mu ne res pon se and inf lam ma tory re ac ti ons. The aim of this study is to de ter mi ne the le vels of pro inf lam ma tory cyto ki ne in ter le ukin-6 (IL-6) and an ti-inf lam ma tory cyto ki ne adi po nec tin in the sera of pa ti ents with BD and to assess their im por tan ce as bi o lo gi cal mar kers for di se a se ac ti vity. M Ma a t te e r ri i a al l a an nd d M Me et t h ho od ds s: : Forty-four BD pa ti ents [19 ma les, 25 fe ma les, age: 35.65 ± 10.84 yrs (me an ± stan dart de vi a ti on) (SD)] and 25 he althy con trols (10 ma les, 15 fe ma les, age: 29.80 ± 8.20 yrs) we re inc lu ded in the study. Pa ti ents we re divided into ac ti ve or inac ti ve gro ups ac cor ding to the ir cli ni cal and la bo ra tory fin dings (acti ve, n= 21; inac ti ve, n= 23). We de ter mi ned se rum IL-6 le vels using the che mi lu mi nes cen ce method, and se rum adi po nec tin le vels by ELI SA met hod. Re sults we re ex pres sed as me an ± stan dard er ror (SE). R Re e s su ul lt ts s: : Se rum le vels of IL-6 and adi po nec tin in BD pa ti ents (n= 44) (5.24 ± 0.84 pg/mL; 22.31 ± 1.71 µg/mL, res pec ti vely) we re si mi lar to the con trol gro up (n= 25) (4.59 ± 1.01 pg/mL; 21.68 ± 1.91 µg/mL, res pec ti vely). No sig ni fi cant dif fe ren ce was fo und in IL-6 and adi po nec tin le vels bet we en the ac ti ve (n= 21), inac ti ve (n= 23) and con trol (n= 25) gro ups. C Co on nc c l lu u s si i o on n: : In pa ral lel with the pre sen ce of inf lam ma ti on and in cre a sed CRP, eryt hrocy te se di men ta ti on ra te and white blood cell co unt, hig her IL-6 and lo wer adi po nec tin le vels were ex pec ted in ac ti ve BD pa ti ents com pa red to the con trols. However, they were found to be si mi lar in all gro ups. We conc lu de that on go ing an ti-inf lam ma tory tre at ment sho uld be ta ken in to con si de ra ti on whi le in ter pre ting the cyto ki ne levels in the se pa ti ents. K Ke ey y W Wo or rd ds s: : Beh cet's syndro me; adi po ki nes; in ter le u kin-6 Ö ÖZ ZE ET T A Am ma aç ç: : Beh çet has ta lı ğı (BH), kro nik sis te mik inf la ma tu ar bir has ta lık olup eti yo pa to ge ne zi he nüz bi lin me mek te dir. İmmun ce vap ve inf la ma tu var sü reç iliş ki sin de si to kin ler rol oy na mak tadır lar. Bu ça lış ma nın ama cı, BH'lı has ta la rın se rum la rın da pro-inf la ma tu ar bir si to kin olan IL-6 ile an ti-inf la ma tu ar si to kin olan adi po nek ti nin se vi ye le ri ni öl çe rek, bun la rın has ta lı ğın ak ti vi te sin de bi yo lo jik be lir teç ola rak et ki le ri ni be lir le mek tir. G Ge e r re eç ç v ve e Y Yö ön n t te em m l le er r: : Ça lış ma ya 44 BH'lı has ta (19 er kek, 25 ka dın, yaş or ta la ma sı 35.65 ± 10 yıl) ve kon trol gru bu ola rak da 25 sağ lık lı ki şi (10 er kek, 15 ka dın, yaş or ta la ma sı 29.80 ± 8.20 yıl) alın mış tır. Has ta lar kli nik ve la bo ra tu var bul gu la rı na gö -re ak tif (n: 21) ve inak tif (n: 23) gru ba ay rıl dı lar. Se rum IL-6 se vi ye si ke mi lu mi ne sens me tod ile, serum adi po nek tin se vi ye si ise ELI SA yön te mi ile öl çül müş tür. So nuç lar arit me tik or ta la ma ± stan dart ha ta ola rak be lir til miş tir. B Bu ul l g gu u l la ar r: : Tüm BH'lı has ta la rın se rum IL-6 ve adi po nek tin se vi ye le ri sı -ra sıy la 5.24 ± 0.84 pg/mL ve 22.31 ± 1.71 µg/mL: sağ lık lı kon trol gru bun da ise 4.59 ± 1.01 pg/mL ve 21.68 ± 1.91 µg/mL ola rak ben zer bu lun muş tur. Se rum IL-6 ve adi po nek tin se vi ye le ri ak tif ve inaktif BH'lı has ta lar ve sağ lık lı kon trol gru bu ara sın da kar şı laş tı rıl dı ğın da aradaki fark is ta tis tik ola rak an lam lı bu lun ma mış tır. S So o n nu uç ç: : İnf la mas yon var lı ğı, art mış C re ak tif pro te in se vi ye si, erit ro sit se dimen tas yon hı zı ve lö ko sit sa yı sı na pa ra lel ola rak se rum IL-6 se vi ye si nin yük sel miş, adi po nek ti nin ise dü şük bu lun ma sı bek len me si ne rağ men bunlar tüm grup lar da ben zer se vi ye ler de bu lun muş tur. BH'lı has ta lar da se rum si to kin se vi ye le ri ni de ğer len di rir ken an ti-inf la ma tu ar te da vi nin du ru mu nu da ele al mak ge rek ti ği so nu cu na var mış bu lun mak ta yız.
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K Ke ey y W Wo or rd ds s: : Beh cet's syndro me; adi po ki nes; in ter le u kin-6 Ö ÖZ ZE ET T A Am ma aç ç: : Beh çet has ta lı ğı (BH), kro nik sis te mik inf la ma tu ar bir has ta lık olup eti yo pa to ge ne zi he nüz bi lin me mek te dir. İmmun ce vap ve inf la ma tu var sü reç iliş ki sin de si to kin ler rol oy na mak tadır lar. Bu ça lış ma nın ama cı, BH'lı has ta la rın se rum la rın da pro-inf la ma tu ar bir si to kin olan IL-6 ile an ti-inf la ma tu ar si to kin olan adi po nek ti nin se vi ye le ri ni öl çe rek, bun la rın has ta lı ğın ak ti vi te sin de bi yo lo jik be lir teç ola rak et ki le ri ni be lir le mek tir. G Ge e r re eç ç v ve e Y Yö ön n t te em m l le er r: : Ça lış ma ya 44 BH'lı has ta (19 er kek, 25 ka dın, yaş or ta la ma sı 35.65 ± 10 yıl) ve kon trol gru bu ola rak da 25 sağ lık lı ki şi (10 er kek, 15 ka dın, yaş or ta la ma sı 29.80 ± 8.20 yıl) alın mış tır. Has ta lar kli nik ve la bo ra tu var bul gu la rı na gö -re ak tif (n: 21) ve inak tif (n: 23) gru ba ay rıl dı lar. Se rum IL-6 se vi ye si ke mi lu mi ne sens me tod ile, serum adi po nek tin se vi ye si ise ELI SA yön te mi ile öl çül müş tür. So nuç lar arit me tik or ta la ma ± stan dart ha ta ola rak be lir til miş tir. B Bu ul l g gu u l la ar r: : Tüm BH'lı has ta la rın se rum IL-6 ve adi po nek tin se vi ye le ri sı -ra sıy la 5.24 ± 0.84 pg/mL ve 22.31 ± 1.71 µg/mL: sağ lık lı kon trol gru bun da ise 4.59 ± 1.01 pg/mL ve 21.68 ± 1.91 µg/mL ola rak ben zer bu lun muş tur. Se rum IL-6 ve adi po nek tin se vi ye le ri ak tif ve inaktif BH'lı has ta lar ve sağ lık lı kon trol gru bu ara sın da kar şı laş tı rıl dı ğın da aradaki fark is ta tis tik ola rak an lam lı bu lun ma mış tır. S So o n nu uç ç: : İnf la mas yon var lı ğı, art mış C re ak tif pro te in se vi ye si, erit ro sit se dimen tas yon hı zı ve lö ko sit sa yı sı na pa ra lel ola rak se rum IL-6 se vi ye si nin yük sel miş, adi po nek ti nin ise dü şük bu lun ma sı bek len me si ne rağ men bunlar tüm grup lar da ben zer se vi ye ler de bu lun muş tur. BH'lı has ta lar da se rum si to kin se vi ye le ri ni de ğer len di rir ken an ti-inf la ma tu ar te da vi nin du ru mu nu da ele al mak ge rek ti ği so nu cu na var mış bu lun mak ta yız. ultisystemic involvement in BD was intro du ced by the stu di es per for med af ter it had be en de fi ned by Prof. Dr. Hu lu si Beh çet in 1937, as a di se a se cha rac te ri zed by uve itis with hypop yon, oral and ge ni tal ul ce ra ti ons. 1 The eti o pat ho ge ne sis of BD, which is con si de red as an im mu no inf lam ma tory di sor der, 2 has not yet been comp le tely de fi ned in de ta il. Ge ne tic factors, infec ti on, im mu nog lo bu lins, im mu ne-comp le xes, an ti bo di es and oxi da ti ve stress ha ve be en al le ged as the ca u ses of BD. [3] [4] [5] Eve rek li og lu et al and Bul danli og lu et al, po in ted out that nit ric oxi de le vels were in cre a sed in BD pa ti ents and this increase was as so ci a ted to ac ti va ti on of the di se a se. 6, 7 Cyto ki nes are low-mo le cu lar-we ight bi o ac tive poly pep ti des func ti o ning in in ter cel lu lar commu ni ca ti ons. 8 In inf lam ma tory di se a ses, it is con si de red that the re is a re la ti ons hip bet we en cyto ki nes, T cells and oxi da ti ve stress. 8 It has be en be en known that pro inf lam ma tory cyto ki nes aggra va te oxi da ti ve stress by in cre a sing the sec re ti on of nit ric oxi de from en dot he li al cells. In the sa me way, ho mocy ste i ne sti mu la tes the ex pres si on of che mo at trac tants by in cre a sing the synthe sis of nit ric oxi de in the en dot he li al cells, and it is sig ni ficantly re la ted to cyto ki nes. 9, 10 Stu di es on cyto ki ne pro fi le in BD have yielded conf lic ting re sults. 8, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Adi po nec tin is an adi pocy to ki ne which was de fi ned first and it is the major pro te in produced by the adi pocy tes. It is a cen tral re gu la tory pro te in con trol ling li pid and car bohy dra te me ta bo lism in many physi o lo gic path ways and it me di a tes va ri ous vas cu lar pro ces ses. Adi po nec tin ex hi bits both an ti-inf lam ma tory and an ti-at he ro ge nic pro per ties. 21 In con trary to ot her adi pocy to ki nes, adi po nectin le vels dec re a se pa ra do xi cally in ca ses with in su lin re sis tan ce inc lu ding obe sity, me ta bo lic syndro me, hyper ten si on and co ro nary ar te ri al di se ases.
In li te ra tu re, the re is only one study in which se rum adi po nec tin le vels we re measured, per formed by Oguz et al. 22 This study re por ted that no sta tis ti cally sig ni fi cant dif fe ren ce was fo und betwe en the BD gro up and the he althy vo lun te ers in terms of se rum adi po nec tin le vels.
In our study in or der to un ders tand the eti opat ho ge ne sis of BD bet ter by me a su ring the le vels of IL-6, which is a pro inf lam ma tory cyto ki ne and an ti-inf lam ma tory cyto ki ne adi po nec tin, we ai med to in ves ti ga te the re la ti ons hips of the se two cytoki nes with the ac ti vity of the di se a se.
MA TE RI AL AND MET HODS
Forty-fo ur pa ti ents (19 ma les, 25 fe ma les; me an age 35 ye ars; ran ge 16-60) with BD and twenty-fi ve healthy con trol sub jects (10 ma les, 15 fe ma les; me an age 29 ye ars; ran ge 19-45) from a si mi lar eth nic back gro und we re inc lu ded in the study. Sub jects with syste mic di sor der such as re nal or he pa tic di se a ses, di a be tes pregnant patients and pa ti ents on an ti o xi dant the rapy we re exc lu ded from the study. The di ag no sis of BD was ma de ac cor ding to the crite ri a of the In ter na ti o nal Study Gro up for BD. 23 The et hic com mit te e of our hos pi tal ap pro ved the pro to col and in for med con sent was ob ta i ned from all par ti ci pants.
Ac ti ve (n= 21) and inac ti ve (n= 23) BD pa tients we re de ter mi ned by cli ni cal and la bo ra tory fin dings. In cli ni cal eva lu a ti on, ha ving at le ast three of the ma jor symptoms at the ti me of study (oral ul cers, ge ni tal ul cers, skin le si ons, uve i tis, po si ti ve pat hergy test) we re con si de red to indicate the ac tive pe ri od of the di se a se. Pa ti ents in re mis si on, lacking the se ac ti vity symptoms we re eva lu a ted as inac ti ve pa ti ents. In the la bo ra tory in ves ti ga ti ons, the se rum C-reactive protein (CRP) le vels, erythrocyte sedimentation rate (ESR) and white blood cell count (WBC) we re de ter mi ned.
Of 44 BD pa ti ents, 25 (56.8%) we re on colc hici ne tre at ment, five 5 (11.36%) we re on colc hi cine+ste ro id tre at ment, two (4.54%) we re on colc hi ci ne+non ste ro id an ti -if lam ma tory drug treat ment, one (2.27%) was on colc hi ci ne+azot hi o puri ne tre at ment, one (2.27%) was on in ter fe ron-α-2a and one (2.27%) was re ce i ving cyclos po ri ne tre atment.
Seven mililiters of who le blo od samp les we re ob ta i ned by ve ni punc tu re from a pe rip he ral ve in and put in to a pla in tu be for li pid pro fi le, CRP, IL-6 and adi po nec tin; 1.5 mL blood was put into a K 3 -eth yle ne di a mi ne tet ra a ce tic acid (ED TA)-con ta iTurkiye Klinikleri J Med Sci 2010;30 (6) 1838 Etem ve ark.
ning tu be for WBC and 1.6 mL blood was put into a so di um cit ra te (3.2%; 0.4 mL) con ta i ning tu be for ESR. Blood samples were obtained in du ring res ting po si ti on bet we en 08.00-10.00 a.m. ho urs. The pla in tu be was cen tri fu ged at 1500 x g for 10 mi nu tes. Se rum was se pa ra ted and kept at -80° C un til the ti me of IL-6 and adi po nec tin analy sis. IL-6 and adi po nec tin le vels we re de tec ted wit hin 6 months. ESR, WBC and con cen tra ti ons of se rum to tal choles te rol (Tot-C), trigl yce ri de (TG), HDL-cho les te rol (HDL-C) and CRP we re de ter mi ned on the sa me day. The blo od samp les we re ta ken in both ac ti ve and inac ti ve pe ri ods of eight pa ti ents with BD.
The ESR was de ter mi ned by Eri li ne AR au toma ted analy zer (Li ne ar Che mi cals, I.L., Bar ce lo na, Spa in). WBC was co un ted by Ad vi a 120 he ma tology system (Si e mens, Ger many). The con cen tra tions of Tot-C, TG and HDL-C in se rum we re me a su red by Mo du lar DP au to a naly ser (Roc he Diag nos tics, Frank furt, Ger many). LDL-C was cal cula ted by Fri e de wald for mu la. The CRP con cen tra ti on was me a su red in the se rum by a BN-II au to ma ted nep he lo me ter (Si e mens-Da de Behring, West Sac ra men to, U.S.A.).
IL-6 analy sis was per for med ac cor ding to the Im mu li te 2000 che mi lu mi nes cent enz yme im muno met ric as say (Si e mens-Di ag nos tic Pro ducts Corpo ra ti on, Los An ge les, U.S.A.). Se rum adi po nec tin le vels we re me a su red by As say Max ELI SA Kit (St Char les, MO, U.S.A.).
STA TIS TI CAL ANALY SIS
Re sults we re analy zed sta tis ti cally by using one way ANOVA for the des crip ti ve analy sis and Tukey HSD for the mul tip le com pa ri sons among the thre e gro ups. The va lu es of all BD pa ti ents and the con trol gro up we re com pa red using Stu dent's t and Mann-Whit ney U tests. P< 0.05 was con si de red sig ni fi cant. Wil co xon test was per for med for compa ring the re sults of the sa me pa ti ent du ring ac ti ve and inac ti ve pe ri ods. Pe ar son test was used for corre la ti on analy sis. The SPSS Inc.Pac ka ge Prog ram (Chi ca go, IL, U.S.A.) was used for all sta tis ti cal analy ses.
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RE SULTS
Tab le 1 and 2 show the cli ni cal ma ni fes ta ti ons of to tal, ac ti ve and inac ti ve BD pa ti ents, res pec ti vely.
Tab le 3 shows the de mog rap hic and la bo ra tory fin dings of the gro ups.
Tab le 4 shows the com pa ri sons of the pa ra meters re la ted to the ac ti ve and inac ti ve pe ri ods of 8 pa ti ents with BD.
DIS CUS SI ON
In stu di es it has be en ob ser ved that enz yma tic and no nenz yma tic an ti o xi dant mo le cu les dec re a sed and in di ca tors for oxi da ti ve stress in cre a sed in the se ra of BD pa ti ents. 5, [24] [25] [26] Be ing a mul ti func ti o nal pro inf lam ma tory cyto ki ne re gu la ting im mu ne res pon se, IL-6 is pro duced by mo nocy tes, epit he li al cells and fib rob lasts and it ca u ses poly clo nal B cell ac ti va ti on, hypergam mag lo bu li ne mi a and T cell ac ti va ted au to an tibody pro duc ti on. 27, 28 It was po in ted out that the sec re ti on of acu te pha se re ac tants en han ces the pro li fe ra ti on and dif fe ran ti a ti on of the cells. 29 It was de tec ted that over pro duc ti on of IL-6 was obser ved in so me au to im mu ne di se a ses and chro nic inf lam ma tory re ac ti ons. 30 A col la gen li ke pro te in na med adi po nec tin which is sec re ted from adi po se tis su e is emp ha sized to be an im por tant an ti-at he ro ge nic, an ti di abe tic and an ti-inf lam ma tory pro te in in re cent stu di es. 31 When the en dot he li al bar ri er is da ma ged, be ing sus cep tib le to mec ha ni cal stress and che mical com po unds such as oxi di zed LDL, adi po nec tin bin ds su ben dot he li al col la gen ac cu mu la ted in the su ben dot he li al spa ce of vas cu lar walls whe re it mani fests its an ti-at he ro ge nic pro per ti es. 32 Adi po nectin in hi bits ex pres si ons of ad he si on mo le cu les by in hi bi ting ac ti va ti on of NF-κ-B. Thus adi po nec tin pre vents mo nocy tes from ad he ring to vas cu lar endot he li al cells. 33 Adi po nec tin al so im pa irs the vascu lar smo oth musc le cel lu lar pro li fe ra ti on in du ced by growth fac tor in hi bi ti on of mi to gen ac ti va ted pro te in ki na se. 34 In the light of this in for ma ti on, we in ves ti gated the le vels of Tot-C, TG, HDL-C, LDL-C, CRP, ESR, WBC, IL-6 and adi no pec tin in 44 BD pa ti ents, in ac ti ve and inac ti ve pe ri ods of 8 pa ti ents with BD, and investigated the ir re la ti ons hips with di se a se acti va ti on.
We ob ser ved that the se rum TG le vels of ac tive, inac ti ve and to tal pa ti ent gro ups we re sig ni ficantly hig her and HDL-C le vels we re sig ni fi cantly lo wer in com pa ri son to the con trol gro up. We detec ted that the LDL-C le vels of inac ti ve, ac ti ve and to tal pa ti ent gro ups we re sig ni fi cantly hig her in com pa ri son to those of the con trol gro up. Our findings on li pid le vels are com pa tib le with that of San dik ci, 5 Mi ta mu ra, 35 Orem 24, 36, 37 and Cham bers 38 et al. In BD, as a re sult of an in cre a se in TG and LDL-C le vels, li pids and li pop ro te ins ex po sed to oxi da ti ve stress de ve lop li pid pe ro xi da ti on pro ducts. The re fo re, this may be the res pon sib le fac tor of endot he li al dysfunc ti on in BD. Our fin dings on li pids and li pop ro te ins sup port that oxi da ti ve stress plays a ro le in vas cu lar inf lam ma tory in ci dents in eti opat ho ge ne sis of BD.
In our study, when we com pa red IL-6 and adino pec tin le vels in ac ti ve, inac ti ve and to tal pa ti ent gro ups, we co uld not find any sig ni fi cant dif fe rences bet we en the gro ups. Stu di es on cyto ki ne pro file in BD hawe shown conf lic ting re sults . Many in vi vo stu di es ha ve de mons tra ted that TNF-α, IL-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17, IL-18, G-CSF and IFN-γ were all im por tant com po nents of the pro inf lam ma tory res pon se in BD. 8, [11] [12] [13] [14] [15] [16] [17] [18] Me ge et al. fo und that the spon ta ne o us sec re ti on of TNF-α, Turkiye Klinikleri J Med Sci 2010;30 (6) IL-6 and IL-8 by mo nocy tes was sig ni fi cantly incre a sed in pa ti ents with ac ti ve BD. 11 Tu ran et al. re por ted that IL-10 and IL-12 were in cre a sed in BD and IL-12 had a cor re la ti on with ac ti va ti on. 12 Yama ka wa et al. exa mi ned the le vels of IL-6 in plasma and su per na tants of pe rip he ral blo od mo no nuc le ar cells (PBMC) from BD pa ti ents and he althy con trols using a sen si ti ve ELI SA. 13 The IL-6 con cen tra ti ons in cul tu re su per na tants of pa ti ents with ac ti ve BD we re sig ni fi cantly high when compa red to pa ti ents with inac ti ve di se a se and the controls. They re por ted that IL-6 might play a ro le in the pat ho ge ne sis of BD. Na wa ta et al. spe cu la ted that the re pe a ted feb ri le epi so des might ha ve be en ma ni fes ta ti ons of ne ut rop hil hyper func ti on in duced by in cre a sed blo od le vels of inf lam ma tory cyto ki nes, inc lu ding IL-6, IL-8 and G-CSF, in as so ci a ti on with ra re comp li ca ti ons of BD. 14 Ham za o u i et al. re por ted hig her IL-6 le vels in ac ti ve and inac ti ve pa ti ent gro ups in com pa ri son to the con trol gro up. 15 Eve rek li og lu et al. re por ted that IL-6 was a key ac ti va tor of acu te pha se respon se and the in cre a se might be res pon sib le for the in cre a se in the synthe sis of acu te pha se re ac tants in the li ver, and thus IL-6 had an im por tant ro le in the co ur se of BD. 8 They de tec ted sig ni fi cantly higher le vels of acu te pha se re ac tants; ne ut rop hil count, ESR, α-1-an tit rip sin and α-2-mac rog lo bu lin in the ac ti ve pa ti ent gro up in com pa ri son to the inac ti ve and the con trol gro ups. They al so de tec ted sig ni fi cantly hig her le vels of the se pa ra me ters in the inac ti ve pa ti ent gro up in com pa ri son to the con trol gro up. Bar dak et al. de tec ted sig ni fi cantly hig her se rum le vels of IL-6, IL-8 ve TNF-α in BD pa ti ents with ac ti ve uve tis in com pa ri son to the remis si on pe ri od of the sa me pa ti ent gro up and healthy in di vi du als. 16 Adam et al. fo und sig ni fi cantly hig her le vels of CRP and IL-6 in the ac ti ve BD pati ent gro up in com pa ri son to the con trol gro up. 17 Ak de niz et al. fo und sig ni fi cantly hig her se rum levels of IL-6, IL-8 and TNF-α in BD in com pa ri son to the con trol gro up. 18 On the ot her hand, al-Da la an et al. re por ted that se rum le vels of IL-6, TNF-α and IFN-γ we re not sig ni fi cantly ele va ted in pa ti ents with BD. 19 Sayi nalp et al. simiarly fo und that se rum le vels of IL-1 be ta, IL-2 and IL-6 in the pa ti ents with BD we re si mi lar to the con trol gro up, but se rum le vels of sIL-2R and TNF-α we re hig her in pa ti ents with BD com pa red to con trols. 20 Our fin dings on se rum IL-6 le vels are inconsistent with tho se of Me ge, Turan, Ya ma ka wa, Na wa ta, Ham za o u i, Eve rek li og lu, Bar dak, Adam, Ak de niz et al., however they are consistent with tho se of al-Da la an, and Sa yi nalp et al. 8, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] The only study in li te ra tu re in which se rum adi no pec tin le vel is in ves ti ga ted in BD was per formed by Oguz et al. 22 In this study, se rum adi no pectin le vels we re not sig ni fi cantly dif fe rent in BD in com pa ri son to the he althy con trol gro up. The ir pati ent gro up ma ni fes ted si mi la ri ti es to our pa ti ents be ca u se 86.8% of the pa ti ents used colc hi ci ne, 2.6% used ste ro id and 5.3% used im mu no sup res si ves. Our fin dings on adi no pec tin le vels over lap with tho se of Oguz et al. 22 We suppose that the re a son of conf lic ting results in terms of IL-6 le vels ema na tes from the vari a ti on of me a su re ment met hods and/or drug/me di ca ti on used in pa ti ents inc lu ded in the study, as well as the du ra ti on of the therapy. Everek li og lu et al. re por ted that they exc lu ded the pati ents using glu co cor ti co ids and im mu no sup ressi ves that dec re a sed the trans crip ti on of pro inflam ma tory cyto ki nes. 8 Be ca u se of the me di cal condi ti ons of our pa ti ents it was not pos sib le for them to stop the ir an ti-inf lam ma tory/im mu no sup pres sive me di ca ti ons. Thus, we only exc lu ded the pa tients on an ti o xi dant me di ca ti ons. Of the 44 BD pa ti ents, 25 (56.8%) we re on colc hi ci ne tre at ment, five (11.36%) we re on colc hi ci ne+ste ro id tre atment, two (4.54%) we re on colc hi ci ne+non ste roid an ti-inf lam ma tory drug tre at ment, one (2.27%) was on colc hi ci ne+azot hi o pu ri ne tre at ment, one (2.27%) was on in ter fe ron-α-2a and one (2.27%) was re ce i ving cyclos po ri ne tre at ment. It has be en known that colc hi ci ne in hi bits fib ro nec tin and alve o lar mac rop ha ge de ri ved growth fac tor sec re ti on from al ve o lar mac rop ha ges; it in hi bits cel lu lar repli ca ti on by bin ding tu bu li ne and it ma ni fests an anti fib ro tic ef fect by in hi bi ting cyto ki ne re le a se from po li morp ho nuc le ar le u kocy tes. It was conc lu ded that, be ca u se of colc hi ci ne and ot her an ti-inf lam -ma tory/im mu no sup res si ve drugs used by both acti ve and inac ti ve pa ti ents, se rum IL-6 and adi nopec tin le vels we re dep res sed and du e to that, the re we re no dif fe ren ces bet we en the gro ups in terms of cyto ki nes.
Alt ho ugh 79.5% of the pa ti ents used ste ro i dnon ste ro id an ti-inf lam ma tory/im mu nu sup res si ve me di ca ti on, ESR, WBC and CRP le vels we re me asu red to dif fe ren ti a te the ac ti ve BD pa ti ents from the inac ti ve BD pa ti ents. The le vels of the se pa rame ters we re sig ni fi cantly hig her in the ac ti ve and to tal pa ti ent gro ups when compared to the con trol gro up. In the ac ti ve pa ti ent gro up, only ESR was sig ni fi cantly hig her when compared to inac ti ve pati ent gro up. We conc lu ded that, in con trary to IL-6 and adi po nec tin, the se acu te pha se re ac tants, in spi te of drug or me di ca ti ons, yi el ded tru e in for mati on to dif fe ren ti a te BD pa ti ents from he althy in divi du als, and only ESR can be used to dif fe ren ti a te the ac ti ve pha se of the di se a se from the inac ti ve pha se. Alt ho ugh IL-6 is known as a key ac ti va tor of acu te pha se res pon se, in our study, IL-6 did not in cre a se in se rum of the pa ti ents with BD. Thus, fac tors ot her than cyto ki ne in du cing ESR in cre a se sho uld be con si de red in BD.
We co uld not find any sta tis ti cally sig ni fi cant dif fe ren ces in the blood samples obtained du ring ac ti ve and inac ti ve pe ri ods of eight pa ti ents with BD in terms of li pids, acu te pha se reactants or cyto ki ne le vels. We conc lu ded that this re sult emana ted from the ef fects of the drugs on se rum le vels of the se pa ra me ters.
In conclusion, an ti-inf lam ma tory and im muno sup res si ve drugs used in BD pa ti ents dep ress proinf lam ma tory and an ti-inf lam ma tory cyto ki ne le vels. The re fo re we conc lu de that it is con ve ni ent to eva lu a te the im por tan ce of pro-inf lam ma tory and an ti-inf lam ma tory cyto ki nes in ac ti ve or inac ti ve pha ses by me a su ring the cyto ki nes in newly di agno sed BD pa ti ents who are not on any me di ca ti on.
